The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Omega-3 long chain fatty acid “bioavailability”: A review of evidence and methodological considerations
Open accessAbstract
This review considers the bioavailability of different forms of omega-3 long chain polyunsaturated fatty acids (n-3 LC-PUFA), including ethyl esters (EEs), free fatty acids (FFAs), triacylglycerols (TAGs) and phospholipids (PLs). The retrieved studies include short-term and longer-term studies in humans, and a number of animal studies, which were highly heterogeneous in their design making it difficult to draw substantiated conclusions. The apparent bioavailability (as defined by the authors of these studies) seems to be lowest for the EE form and highest for the FFA form, whilst no conclusion can be made for TAG versus PL from human data. Animal studies suggest that there are substantial differences in the bioavailability of PL form of LC-PUFA compared with the TAG form. This apparent limited knowledge and understanding is fundamentally driven by methodological limitations of these studies. The major limitations with the studies to date include: (between studies) loose definition of the term "bioavailability", lack of standardisation of analytical methodology, and differences in which blood compartment was analysed; (within a study) failure to provide equal amounts the n-3 LC-PUFA of the different forms being compared, failure to provide the dose of n-3 LC-PUFA on a body weight basis, failure to measure fatty acid excretion, failure to control the total fat intake, and failure to adequately power the studies from a statistical point of view. This review has laid out a set of suggestions and criteria for conducting future studies on the bioavailability of different chemical forms of n-3 LC-PUFA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(n-3) Fatty Acids and Cardiovascular Health: Are Effects of EPA and DHA Shared or Complementary?
Mozaffarian, D., & Wu, J. H. Y. (2012) · The Journal of Nutrition · doi:10.3945/jn.111.149633 · Cited by 368
Docosapentaenoic acid (22:5n-3): A review of its biological effects
Kaur, G., Cameron-Smith, D., Garg, M., & Sinclair, A. J. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.07.004 · Cited by 337
Bioavailability of marine n-3 fatty acid formulations
Dyerberg, J., Madsen, P., Møller, J. M., Aardestrup, I., & Schmidt, E. B. (2010) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2010.06.007 · Cited by 256
Rossmeisl, M., Macek Jilkova, Z., Kuda, O., Jelenik, T., Medrikova, D., Stankova, B., Kristinsson, B., Haraldsson, G. G., Svensen, H., Stoknes, I., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038834 · Cited by 230
Davidson, M. H., Johnson, J., Rooney, M. W., Kyle, M. L., & Kling, D. F. (2012) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2012.01.002 · Cited by 191 · cited 6×
“1 g [11] of EPA or EPA plus DHA to healthy subjects [8–12,14] or to overweight subjects [15]; amounts that are above the normally recommended intake levels.”
BackgroundMethodResultInfluentialRamprasath, V. R., Eyal, I., Zchut, S., & Jones, P. J. (2013) · Lipids in Health and Disease · doi:10.1186/1476-511x-12-178 · Cited by 175
Cited by
Saini, R. K., & Keum, Y.-S. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.04.049 · Cited by 1,281
Watson, H., Mitra, S., Croden, F. C., Taylor, M., Wood, H. M., Perry, S. L., Spencer, J. A., Quirke, P., Toogood, G. J., Lawton, C. L., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-314968 · Cited by 506
Very long-chain n -3 fatty acids and human health: fact, fiction and the future
Calder, P. C. (2018) · Proceedings of the Nutrition Society · doi:10.1017/s0029665117003950 · Cited by 419
Maki, K. C., Bobotas, G., Dicklin, M. R., Huebner, M., & Keane, W. F. (2017) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2016.10.010 · Cited by 20
Targeting neuroinflammation: The therapeutic potential of ω-3 PUFAs in substance abuse
Peng, S., Peng, Z., Qin, M., Huang, L., Zhao, B., Wei, L., Ning, J., Tuo, Q.-H., Yuan, T.-F., Shi, Z., et al. (2021) · Nutrition · doi:10.1016/j.nut.2020.111058 · Cited by 18
Metadata
- Authors
- Ghasemifard, S., Turchini, G. M., & Sinclair, A. J.
- Venue
- Progress in Lipid Research
- Publisher
- Elsevier BV
- Published
- 2014-10
- Volume
- 56
- Pages
- 92-108
- ISSN
- 0163-7827 (ISSN-L)
- OpenAlex
- W2057006290
- Cited by
- 167
- References
- 6
- FWCI
- 10.75
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Omega-3 long chain fatty acid “bioavailability”: A review of evidence and methodological considerations. https://app.cochat.ai/papers/10.1016/j.plipres.2014.09.001
- The paper
- Ghasemifard, S., Turchini, G. M., & Sinclair, A. J. (2014). Omega-3 long chain fatty acid “bioavailability”: A review of evidence and methodological considerations. Progress in Lipid Research. https://doi.org/10.1016/j.plipres.2014.09.001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.